The Future of Artificial Intelligence in Veterinary Diagnostics

Veterinary medicine is undergoing a significant transformation, driven by advancements in technology and the growing complexity of pet care. Veterinarians today face a range of challenges, from increasing caseloads and workforce shortages to the need for faster, more accurate diagnostics. As the profession evolves, innovation in diagnostic tools is becoming a critical part of improving patient outcomes and streamlining veterinary workflows.

Clinics are often operating under significant time constraints, with veterinarians needing to make quick and informed decisions while managing a high volume of patients. At the same time, accuracy in diagnostics remains paramount to ensuring the best possible care. Traditional methods can be time-consuming and prone to variability, leading to delays in treatment or the need for additional testing.

One area where artificial intelligence (AI) is making an impact is hematology, with advanced analyzers able to detect and identify blood cell abnormalities with a level of speed and precision that was previously unattainable in routine veterinary practice.

Beyond hematology, AI is also playing a role in areas such as urinalysis and imaging. By integrating AI into diagnostic platforms, veterinary practices can reduce the burden on staff while enhancing their ability to diagnose and treat a wide range of conditions. Additionally, connectivity solutions are improving data accessibility, ensuring that veterinarians have the information they need at their fingertips to make timely and effective clinical decisions.

Customer-centric innovation

Understanding the needs of veterinarians is at the core of Zoetis' approach. Every new technology stem from a deep commitment to addressing challenges in the field and enhancing daily operations.

For example, the newest innovation to come from Zoetis Diagnostics, Vetscan OptiCell™, combines innovative technology with AI-powered processing and minimal maintenance to provide automated completed blood count (CBC) analysis.

“Vetscan OptiCell is a wonderful new introduction that builds on the innovation roadmap we've had until now,” explains Abhay Nayak, President of Global Diagnostics at Zoetis. “It's modern technology like AI that makes workflow incredibly simple, but more importantly, it really elevates the standards of care in the practice.”

Expanding the power of Vetscan Imagyst

In addition to Vetscan OptiCell, Zoetis continues to push the boundaries of veterinary diagnostics with its Vetscan Imagyst® platform. The promise of Imagyst was continuous innovation, and the company has delivered. The introduction of AI-driven applications like Vetscan Imagyst AI Urine Sediment Analysis and the Vetscan® Hub connectivity platform have further strengthened the ecosystem, providing veterinary professionals with powerful tools to enhance diagnostic efficiency.

What’s next?

While AI-driven diagnostics are still evolving, the potential for the technology is immense. As adoption grows, these innovations will not only improve operational efficiency but also elevate the standard of care, making advanced diagnostics more accessible to veterinary practices of all sizes.

The future of veterinary medicine lies in leveraging technology to support veterinarians in their mission to provide high-quality care — helping them navigate the challenges of today while preparing for the demands of tomorrow.

With AI-driven diagnostics at the forefront, the future of veterinary medicine is brighter than ever.

Here, Abhay Nayak, President of Global Diagnostics at Zoetis, discusses how diagnostic capabilities are evolving, highlighting the company's expanding portfolio.

For more information, go to www.zoetisdiagnostics.com

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. © 2025 Zoetis Services LLC. All rights reserved. VTS-01704.